MXR

2.17%

4.5¢ maximus resources limited

Ann: $3.2 Million Mill Lease and 50% EGMS Sale Package, page-158

First 158 Last

Share
Profile

Follow
mrbiggz1979

1,252 Posts.

56

02/01/19

16:10

Post #: 37004913
Share

Originally posted by mrbiggz1979: ↑

Mate, just redo your figures and your buy and sell price and it will come good.
It is working the maths out using your the initial purchase cost at 0.001. I.e. 8,696 x 0.001 = $8.696.

The price now is 0.078.
So it calculates 8,696 at that price.
0.078 x 8,696 = $678.29

It thinks you only have spent $8.696 for your 8,696 shares.

Hence, why its saying you are in profit of $668.59.
($678.29 - $8.696 =$669.59)

Just put the buy price at 0.115 and the maths will work itself out.

You are actually in the red of $1,000 - $678.29 = $321.71 (separate to broking) .
This should be represented when you do the purchase price change to 0.115.
*** 8,696 is a rounded up number so you may be down something diff to $321.71 but it will be close enough to that.

Cheers biggz

Expand

Typo

<p>Hence, why its saying you are in profit of $668.59.</p><p>($678.29 - $8.696 =$669.59)</p>

Hence, why its saying you are in profit of $669.59.

MXR Price at posting: 7.4¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BUX

Buxton projects new graphite province discovery at WA Narryer play

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

There are more pages in this discussion • 54 more messages in this thread...

First 158 Last

Add MXR (ASX) to my watchlist

(20min delay)
Last 4.5¢		Change -0.001(2.17%)		Mkt cap ! $19.25M

Open	High	Low	Value	Volume
4.7¢	4.7¢	4.2¢	$42.78K	958.1K

Buyers (Bids)

No.	Vol.	Price($)
1	78891	4.5¢

Sellers (Offers)

Price($)	Vol.	No.
4.6¢	54339	1

View Market Depth

No.	Vol.	Price($)
1	78891	0.045
1	300000	0.044
1	369531	0.043
2	437620	0.042
1	500000	0.041

Price($)	Vol.	No.
0.046	54339	1
0.047	302980	3
0.048	39560	2
0.049	308920	5
0.050	1050367	3

Last trade - 15.35pm 04/10/2024 (20 minute delay)

MXR (ASX) Chart

Ann: $3.2 Million Mill Lease and 50% EGMS Sale Package, page-158

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: $3.2 Million Mill Lease and 50% EGMS Sale Package, page-158

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News